Comparison of Morphine and Remifentanil on the Duration of Weaning from Mechanical Ventilation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: A randomized, multicenter, open‐label, parallel group study was performed to compare the effects of remifentanil and morphine as analgesic drugs on the duration of weaning time from mechanical ventilation (MV). Methods: A total of 96 patients with MV in 6 medical and surgical intensive care units were randomly assigned to either, remifentanil (0.1‐0.2 mcg/kg/min, n = 49) or morphine (0.8‐35 mg/hr, n = 47) from the weaning start. The weaning time was defined as the total ventilation time minus the sum of controlled mode duration. Results: Compared with the morphine group, the remifentanil‐based analgesic group showed a tendency of shorter weaning time (mean 143.9 hr, 89.7 hr, respectively: p = 0.069). Secondary outcomes such as total ventilation time, successful weaning rate at the 7th of MV day was similar in both groups. There was also no difference in the mortality rate at the 7th and 28th hospital day. Kaplan‐Meyer curve for weaning was not different between the two groups. Conclusions: Remifentanil usage during the weaning phase tended to decrease weaning time compared with morphine usage.
Abstract
Background: A randomized, multicenter, open‐label, parallel group study was performed to compare the effects of remifentanil and morphine as analgesic drugs on the duration of weaning time from mechanical ventilation (MV). Methods: A total of 96 patients with MV in 6 medical and surgical intensive care units were randomly assigned to either, remifentanil (0.1‐0.2 mcg/kg/min, n = 49) or morphine (0.8‐35 mg/hr, n = 47) from the weaning start. The weaning time was defined as the total ventilation time minus the sum of controlled mode duration. Results: Compared with the morphine group, the remifentanil‐based analgesic group showed a tendency of shorter weaning time (mean 143.9 hr, 89.7 hr, respectively: p = 0.069). Secondary outcomes such as total ventilation time, successful weaning rate at the 7th of MV day was similar in both groups. There was also no difference in the mortality rate at the 7th and 28th hospital day. Kaplan‐Meyer curve for weaning was not different between the two groups. Conclusions: Remifentanil usage during the weaning phase tended to decrease weaning time compared with morphine usage.
참고문헌 (20)
- "Crit Care", 2005, R200~R210
- Rozendaal FW, "Remifentanil‐propofol analgo‐sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre rand omised, cross‐over, open‐label study in the Netherlands", Intensive Care Med, 35, pp.291~298 (2009)
- Barr J, "Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit", Crit Care Med, 41, pp.263~306 (2013)
- Payen JF, "Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient‐based study", Anesthesiology, 106, pp.687~695 (2007)
- Egan TD, "The pharmacokinetics of the new short‐acting opioid remifentanil (GI87084B) in healthy adult male volunteers", Anesthesiology, 79, pp.881~892 (1993)
- Shapiro BA, "Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine", Crit Care Med, 23, pp.1596~1600 (1995)
- Trescot AM, "Opioid pharmacology", Pain Physician, 11(2 Suppl), pp.S133~S153 (2008)
- Michelsen LG, "The pharmacokinetics of remifentanil", J Clin Anesth, 8, pp.679~682 (1996)
- Kapila A, "Measured context‐sensitive half‐times of remifentanil and alfentanil", Anesthesiology, 83, pp.968~975 (1995)
- Pitsiu M, "Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment", Br J Anaesth, 92, pp.493~503 (2004)
- Steinlechner B, "Low‐dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose‐finding study", Br J Anaesth, 98, pp.598~603 (2007)
- Glass PS, "Preliminary pharmacokinetics and pharmacodynamics of an ultra‐short‐acting opioid: remifentanil (GI87084B)", Anesth Analg, 77, pp.1031~1040 (1993)
- "Crit Care", 2004, R1~R11
- Dahaba AA, "Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study", Anesthesiology, 101, pp.640~646 (2004)
- Wang JY, "Russell GN:Induction of anaesthesia in patients with coronary artery disease:a comparison between sevoflurane‐remifentanil and fentanyl‐etomidate", Anaesth Intensive Care, 27, pp.363~368 (1999)
- Reid JE, "Bradycardia after administration of remifentanil", Br J Anaesth, 84, pp.422~423 (2000)
- Kurdi O, "Asystole during anaesthetic induction with remifentanil and sevoflurane", Br J Anaesth, 87, pp.943~ (2001)
- Nooh N, "Effect of remifentanil on the hemodynamic responses and recovery profile of patients undergoing single jaw orthognathic surgery", Int J Oral Maxillofac Surg, 42, pp.988~993 (2013)
- Gesztesi Z, "The use of a remifentanil infusion for hemodynamic control during intracranial surgery", Anesth Analg, 89, pp.1282~1287 (1999)
- Carrer S1, "Short term analgesia based sedation in the Intensive Care Unit:morphine vs remifentanil + morphine", Minerva Anestesiol, 73, pp.327~332 (2007)